Literature DB >> 21909336

Influenza-induced innate immunity: regulators of viral replication, respiratory tract pathology & adaptive immunity.

Karen L Oslund1, Nicole Baumgarth.   

Abstract

Influenza virus infections usually cause mild to moderately severe respiratory disease, however some infections, like those involving the avian H5N1 virus, can cause massive viral pneumonia, systemic disease and death. The innate immune response of respiratory tract resident cells is the first line of defense and limits virus replication. Enhanced cytokine and chemokine production following infection, however, appears to underlie much of the pathology that develops after infection with highly pathogenic strains. A so-called `cytokine storm' can damage the lung tissue and cause systemic disease, despite the control of viral replication. By summarizing current knowledge of the innate responses mounted to influenza infection, this review highlights the importance of the respiratory tract epithelial cells as regulators of innate and adaptive immunity to influenza virus.

Entities:  

Year:  2011        PMID: 21909336      PMCID: PMC3168512          DOI: 10.2217/fvl.11.63

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  86 in total

1.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors.

Authors:  Stephan Ludwig; Xiuyan Wang; Christina Ehrhardt; Hongyong Zheng; Nicola Donelan; Oliver Planz; Stephan Pleschka; Adolfo García-Sastre; Gudrun Heins; Thorsten Wolff
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 3.  Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.

Authors:  Jeannette Guarner; Reynaldo Falcón-Escobedo
Journal:  Arch Med Res       Date:  2010-01-06       Impact factor: 2.235

4.  Analysis of cytokine secretion from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity influenza viruses.

Authors:  Matthew R Sandbulte; Adrianus C M Boon; Richard J Webby; Janice M Riberdy
Journal:  Virology       Date:  2008-09-17       Impact factor: 3.616

5.  Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses.

Authors:  Saori Sakabe; Kiyoko Iwatsuki-Horimoto; Ryo Takano; Chairul A Nidom; Mai Thi Quynh Le; Tokiko Nagamura-Inoue; Taisuke Horimoto; Naohide Yamashita; Yoshihiro Kawaoka
Journal:  J Gen Virol       Date:  2011-03-02       Impact factor: 3.891

Review 6.  Respiratory epithelial cells in innate immunity to influenza virus infection.

Authors:  Catherine J Sanders; Peter C Doherty; Paul G Thomas
Journal:  Cell Tissue Res       Date:  2010-09-17       Impact factor: 5.249

Review 7.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

8.  Inflammasome recognition of influenza virus is essential for adaptive immune responses.

Authors:  Takeshi Ichinohe; Heung Kyu Lee; Yasunori Ogura; Richard Flavell; Akiko Iwasaki
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

9.  Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages.

Authors:  Suki M Y Lee; Jennifer L Gardy; C Y Cheung; Timothy K W Cheung; Kenrie P Y Hui; Nancy Y Ip; Y Guan; Robert E W Hancock; J S Malik Peiris
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

10.  Re-emergence of fatal human influenza A subtype H5N1 disease.

Authors:  J S M Peiris; W C Yu; C W Leung; C Y Cheung; W F Ng; J M Nicholls; T K Ng; K H Chan; S T Lai; W L Lim; K Y Yuen; Y Guan
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

View more
  38 in total

1.  Lymphocyte-independent pathways underlie the pathogenesis of murine cytomegalovirus-associated secondary haemophagocytic lymphohistiocytosis.

Authors:  E Brisse; M Imbrechts; T Mitera; J Vandenhaute; N Berghmans; L Boon; C Wouters; R Snoeck; G Andrei; P Matthys
Journal:  Clin Exp Immunol       Date:  2018-01-18       Impact factor: 4.330

2.  Murine Model for the Study of Influenza D Virus.

Authors:  J Oliva; J Mettier; L Sedano; M Delverdier; N Bourgès-Abella; B Hause; J Loupias; I Pardo; C Bleuart; P J Bordignon; E Meunier; R Le Goffic; G Meyer; M F Ducatez
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

3.  Macrophage migration inhibitory factor enhances influenza-associated mortality in mice.

Authors:  Candice A Smith; Daniel J Tyrell; Upasana A Kulkarni; Sherri Wood; Lin Leng; Rachel L Zemans; Richard Bucala; Daniel R Goldstein
Journal:  JCI Insight       Date:  2019-07-11

4.  Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia.

Authors:  Mart Toots; Jeong-Joong Yoon; Robert M Cox; Michael Hart; Zachary M Sticher; Negar Makhsous; Roland Plesker; Alec H Barrena; Prabhakar G Reddy; Deborah G Mitchell; Ryan C Shean; Gregory R Bluemling; Alexander A Kolykhalov; Alexander L Greninger; Michael G Natchus; George R Painter; Richard K Plemper
Journal:  Sci Transl Med       Date:  2019-10-23       Impact factor: 17.956

5.  Age-Associated Changes in the Respiratory Epithelial Response to Influenza Infection.

Authors:  Kelly D Chason; Ilona Jaspers; Joel Parker; Subhashini Sellers; Louisa E Brighton; Sally A Hunsucker; Paul M Armistead; William A Fischer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-11-10       Impact factor: 6.053

6.  Survival during influenza-associated bacterial superinfection improves following viral- and bacterial-specific monoclonal antibody treatment.

Authors:  Keven M Robinson; Krishnaveni Ramanan; Joshua M Tobin; Kara L Nickolich; Matthew J Pilewski; Nicole L Kallewaard; Bret R Sellman; Taylor S Cohen; John F Alcorn
Journal:  JCI Insight       Date:  2019-07-25

7.  Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice.

Authors:  Kim S LeMessurier; Yanyan Lin; Jonathan A McCullers; Amali E Samarasinghe
Journal:  Antiviral Res       Date:  2016-08-13       Impact factor: 5.970

8.  Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures.

Authors:  William A Fischer; Kelly D Chason; Missy Brighton; Ilona Jaspers
Journal:  Vaccine       Date:  2014-01-30       Impact factor: 3.641

Review 9.  Primary and long-term B-cell responses in the upper airway and lung after influenza A virus infection.

Authors:  Alexander W Boyden; Allison M Frickman; Kevin L Legge; Thomas J Waldschmidt
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

10.  A Live-Attenuated Equine Influenza Vaccine Stimulates Innate Immunity in Equine Respiratory Epithelial Cell Cultures That Could Provide Protection From Equine Herpesvirus 1.

Authors:  Lila M Zarski; Wendy E Vaala; D Craig Barnett; Fairfield T Bain; Gisela Soboll Hussey
Journal:  Front Vet Sci       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.